Elmiron and Vaginal haemorrhage - from FDA reports


Vaginal haemorrhage is found among people who take Elmiron, especially for people who are 30-39 old , have been taking the drug for < 1 month, also take medication Lamictal, and have Depression. This review analyzes which people have Vaginal haemorrhage with Elmiron. It is created by eHealthMe based on reports of 3,148 people who have side effects when taking Elmiron from FDA, and is updated regularly.



On Jul, 22, 2018

3,148 people reported to have side effects when taking Elmiron.
Among them, 14 people (0.44%) have Vaginal haemorrhage


Number of reports submitted per year:

Could Elmiron cause Vaginal haemorrhage?

Time on Elmiron when people have Vaginal haemorrhage *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Age of people who have Vaginal haemorrhage when taking Elmiron *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 30.77 %
  • 30-39: 30.77 %
  • 40-49: 15.38 %
  • 50-59: 7.69 %
  • 60+: 15.38 %

Top conditions involved for these people *:

  1. Depression: 5 people, 35.71%
  2. Birth Control: 3 people, 21.43%
  3. Stress And Anxiety: 2 people, 14.29%
  4. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 7.14%
  5. High Blood Pressure: 1 person, 7.14%

Top co-used drugs for these people *:

  1. Lamictal: 3 people, 21.43%
  2. Lyrica: 2 people, 14.29%
  3. Zoloft: 2 people, 14.29%
  4. Ambien: 2 people, 14.29%
  5. Lorazepam: 2 people, 14.29%

Top other side effects for these people *:

  1. Stress And Anxiety: 3 people, 21.43%
  2. Mood Swings (an extreme or rapid change in mood): 2 people, 14.29%
  3. Feeling Abnormal: 2 people, 14.29%
  4. Drowsiness: 2 people, 14.29%
  5. Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain): 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

What's next:

You could also:



Related studies

Elmiron

Elmiron has active ingredients of pentosan polysulfate sodium. It is often used in interstitial cystitis (ic). (latest outcomes from Elmiron 3,401 users)

Vaginal haemorrhage

Vaginal haemorrhage (vaginal bleeding) has been reported by people with birth control, endometriosis, depression, rheumatoid arthritis, multiple sclerosis (latest reports from 28,747 Vaginal haemorrhage patients).


Drugs that are associated with Vaginal haemorrhage
Vaginal haemorrhage (1,707 drugs)
Could your condition cause Vaginal haemorrhage
Vaginal haemorrhage (1,459 conditions)
Elmiron side effects
Browse all side effects of Elmiron
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Elmiron and have Vaginal haemorrhage


You are not alone. Join our personalized support groups:


You may be interested in these posts

More posts for: Elmiron, Vaginal haemorrhage

Recent updates

General studies
Active Support Groups
Latest posts

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.